ADVERTISMENT
Listen as Dr. Sportelli examines TD management, emphasizing early detection and intervention. He discusses VMAT2 inhibitors, emerging therapies, and regimen augmentation, offering important insights into optimizing care.
Featured Content
Article
Establishing VMAT2 inhibition as standard practice in tardive dyskinesia managementEvidence-based treatment strategies offer new hope for patients with movement disorders
Article
The importance of early screening and intervention in tardive dyskinesiaTimely detection and treatment can prevent progression and improve patient outcomes
Article
Beyond movement assessment: understanding the burden of untreated tardive dyskinesiaComprehensive evaluation reveals profound impact on daily functioning and quality of life
Article
Integrating tardive dyskinesia management into comprehensive psychiatric careA paradigm shift toward viewing movement disorder treatment as essential to psychiatric stability
ADVERTISMENT




